Literature DB >> 27768569

Refractory Depression, Fatigue, Irritable Bowel Syndrome, and Chronic Pain: A Functional Medicine Case Report.

Gregory Plotnikoff1, Melissa Barber2.   

Abstract

INTRODUCTION: Single-disorder or single-organ-system clinical practice guidelines are often of limited usefulness in guiding effective management of patients with chronic multidimensional signs and symptoms. The presence of multiple long-standing medical problems in a given patient despite intensive medical effort suggests that addressing systemic core imbalances could complement more narrowly focused approaches. CASE
PRESENTATION: A 72-year-old man experiencing longstanding depression, fatigue, irritable bowel syndrome, and chronic pain in the context of additional refractory illnesses was assessed and treated, guided by a system-oriented approach to underlying core imbalances termed functional medicine. This patient was referred from a team of clinicians representing primary care, cardiology, gastroenterology, hematology, and psychology. Prior treatment had been unsuccessful in managing multiple chronic comorbidities. Diagnostic assessment included comprehensive stool and nutritional/metabolic laboratory testing.
RESULTS: The blood-, urine-, or stool-based measurements of relevant markers for multiple systemic issues, including digestion/absorption, inflammation, oxidative stress, and methylation, identified previously unrecognized root causes of his constellation of symptoms. These functional measurements guided rational recommendations for dietary choices and supplementation. The patient experienced steady and significant improvement in his mental health, fatigue, chronic pain, and irritable bowel syndrome-as well as the unexpected resolution of his chronic idiopathic pancytopenia.
CONCLUSION: The success in this case suggests that other patients with chronic, complex, and treatment-refractory illness may benefit from a system-oriented assessment of core imbalances guided by specialized nutritional/metabolic and digestive laboratory testing.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27768569      PMCID: PMC5101099          DOI: 10.7812/TPP/15-242

Source DB:  PubMed          Journal:  Perm J        ISSN: 1552-5767


  10 in total

Review 1.  Dehydroepiandrosterone (DHEA): hypes and hopes.

Authors:  Krzysztof Rutkowski; Paweł Sowa; Joanna Rutkowska-Talipska; Anna Kuryliszyn-Moskal; Ryszard Rutkowski
Journal:  Drugs       Date:  2014-07       Impact factor: 9.546

2.  Evidence based medicine: what it is and what it isn't.

Authors:  D L Sackett; W M Rosenberg; J A Gray; R B Haynes; W S Richardson
Journal:  BMJ       Date:  1996-01-13

Review 3.  Depression's multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways.

Authors:  Michael Maes; Marta Kubera; Ewa Obuchowiczwa; Lisa Goehler; Joanna Brzeszcz
Journal:  Neuro Endocrinol Lett       Date:  2011       Impact factor: 0.765

Review 4.  Primary and secondary coenzyme Q10 deficiency: the role of therapeutic supplementation.

Authors:  Marnie Potgieter; Etheresia Pretorius; Michael S Pepper
Journal:  Nutr Rev       Date:  2013-01-30       Impact factor: 7.110

Review 5.  Coenzyme Q10 depletion in medical and neuropsychiatric disorders: potential repercussions and therapeutic implications.

Authors:  Gerwyn Morris; George Anderson; Michael Berk; Michael Maes
Journal:  Mol Neurobiol       Date:  2013-06-13       Impact factor: 5.590

Review 6.  Markers of Oxidative Stress and Neuroprogression in Depression Disorder.

Authors:  Magdaléna Vaváková; Zdeňka Ďuračková; Jana Trebatická
Journal:  Oxid Med Cell Longev       Date:  2015-05-20       Impact factor: 6.543

7.  Novel Testing Enhances Irritable Bowel Syndrome Medical Management: The IMMINENT Study.

Authors:  Kelly Parsons; Julius Goepp; Bryan Dechairo; Elizabeth Fowler; Nathan Markward; Patrick Hanaway; Teresa McBride; Darryl Landis
Journal:  Glob Adv Health Med       Date:  2014-05

8.  Frequency of abnormal fecal biomarkers in irritable bowel syndrome.

Authors:  Julius Goepp; Elizabeth Fowler; Teresa McBride; Darryl Landis
Journal:  Glob Adv Health Med       Date:  2014-05

Review 9.  Effects of oxidative stress on fatty acid- and one-carbon-metabolism in psychiatric and cardiovascular disease comorbidity.

Authors:  J Assies; R J T Mocking; A Lok; H G Ruhé; F Pouwer; A H Schene
Journal:  Acta Psychiatr Scand       Date:  2014-03-21       Impact factor: 6.392

Review 10.  Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders.

Authors:  John R Kelly; Paul J Kennedy; John F Cryan; Timothy G Dinan; Gerard Clarke; Niall P Hyland
Journal:  Front Cell Neurosci       Date:  2015-10-14       Impact factor: 5.505

  10 in total
  5 in total

1.  Response to Functional Medicine Case Study and Editorial.

Authors:  Craig W Robbins; Meighan Elder; Michelene A Kuhr; Mark S Hoskinson
Journal:  Perm J       Date:  2017

2.  Form Follows Function: A Functional Medicine Overview.

Authors:  Patrick Hanaway
Journal:  Perm J       Date:  2016-10-14

3.  Systems Biology Meets Functional Medicine.

Authors:  Jeffrey S Bland
Journal:  Integr Med (Encinitas)       Date:  2019-10

Review 4.  Biomolecules from Plant Wastes Potentially Relevant in the Management of Irritable Bowel Syndrome and Co-Occurring Symptomatology.

Authors:  Ioana-Miruna Balmus; Dana Copolovici; Lucian Copolovici; Alin Ciobica; Dragos Lucian Gorgan
Journal:  Molecules       Date:  2022-04-08       Impact factor: 4.927

5.  Association of the Functional Medicine Model of Care With Patient-Reported Health-Related Quality-of-Life Outcomes.

Authors:  Michelle Beidelschies; Marilyn Alejandro-Rodriguez; Xinge Ji; Brittany Lapin; Patrick Hanaway; Michael B Rothberg
Journal:  JAMA Netw Open       Date:  2019-10-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.